相关实验视频
Updated: Jan 18, 2026
07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
481
淋巴白血病和败血病患者的死亡率趋势和人口差异
Hiral Undhad1, Pooja Joshi2, Nidhi Patil3
1Internal Medicine, Jiangsu University School of Medicine, Zhenjiang, CHN.
Cureus
|September 12, 2025
概括
淋巴白血病与败血病的死亡率从1999年至2020年增加,特别是在男性和白人个体中. 这凸显了有针对性的公共卫生干预和改善高风险人群获得医疗保健的必要性.
科学领域:
- 血液学 血液学 血液学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 淋巴性白血病是死亡的一个重要原因.
- 淋巴白血病和败血病的同时发生是一个越来越感兴趣的研究领域.
- 了解这种关系对于公共卫生战略和识别风险群体至关重要.
研究的目的:
- 分析淋巴白血病病例的死亡率趋势,其中败血症是导致死亡的因素.
- 为此分析,使用CDC多重死亡原因 (MCD) 数据库.
- 确定这些死亡率趋势中的人口和地理模式.
主要方法:
- 美国疾病预防控制中心MCD数据库 (1999-2020) 的回顾性分析.
- 纳入标准:25岁以上的个体,淋巴细胞白血病是潜在原因,而败血症是导致死亡的原因.
- 按性别,种族,地理区域和死亡地点分层的数据;年龄调整的死亡率 (AAMR) 和年度百分比变化 (APC) 的计算.
主要成果:
- 在1999年至2020年期间,共有17,265人死亡.
- 大多数死亡发生在大都市地区 (82.6%).
- 男性 (62.7%) 和白人 (86.6%) 是死亡率最高的群体,总死亡率为每百万人口3.9%.
结论:
- 在淋巴细胞白血病与败血症中观察到显著增加的死亡率趋势.
- 根据性别和种族,死亡率存在显著差异.
- 这些发现强调了针对性预防策略和改善医疗保健可访问性的必要性.
相关概念视频
01:27Disorders of Leukocytes
1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
01:21Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
01:22Life Tables
506
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
506
01:22Applications of Life Tables
328
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
328
01:20Comparing the Survival Analysis of Two or More Groups
565
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
565